Teladoc Health Inc [TDOC] Revenue clocked in at $2.60 billion, down -32.71% YTD: What’s Next?

Teladoc Health Inc [NYSE: TDOC] price plunged by -4.67 percent to reach at -$0.71. The company report on February 20, 2024 at 4:05 PM that Teladoc Health Reports Fourth Quarter and Full Year 2023 Results.

Fourth quarter 2023 revenue increase of 4% and full year 2023 revenue increase of 8% to $2,602.4 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Fourth quarter 2023 net loss of $28.9 million, or $0.17 per share, and full year 2023 net loss of $220.4 million, or $1.34 per share.

The one-year TDOC stock forecast points to a potential upside of 30.79. The average equity rating for TDOC stock is currently 2.65, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Teladoc Health Inc [TDOC]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TDOC shares is $20.95 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TDOC stock is a recommendation set at 2.65. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

DA Davidson have made an estimate for Teladoc Health Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 17, 2024. While these analysts kept the previous recommendation, Barclays raised their target price to Overweight. The new note on the price target was released on January 03, 2024, representing the official price target for Teladoc Health Inc stock. Previously, the target price had yet another raise to $25, while Stephens analysts kept a Equal-Weight rating on TDOC stock.

The Average True Range (ATR) for Teladoc Health Inc is set at 1.15, with the Price to Sales ratio for TDOC stock in the period of the last 12 months amounting to 0.93. The Price to Book ratio for the last quarter was 1.04, with the Price to Cash per share for the same quarter was set at 6.74. Price to Free Cash Flow for TDOC in the course of the last twelve months was 7.14 with Quick ratio for the last quarter at 3.39.

TDOC Stock Performance Analysis:

Teladoc Health Inc [TDOC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -32.90. With this latest performance, TDOC shares dropped by -28.18% in over the last four-week period, additionally sinking by -36.98% over the last 6 months – not to mention a drop of -50.73% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TDOC stock in for the last two-week period is set at 26.87, with the RSI for the last a single of trading hit 21.27, and the three-weeks RSI is set at 31.29 for Teladoc Health Inc [TDOC]. The present Moving Average for the last 50 days of trading for this stock 20.38, while it was recorded at 17.37 for the last single week of trading, and 21.39 for the last 200 days.

Insight into Teladoc Health Inc Fundamentals:

Teladoc Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.39 and a Current Ratio set at 3.46.


With the latest financial reports released by the company, Teladoc Health Inc posted -0.42/share EPS, while the average EPS was predicted by analysts to be reported at -0.5/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 16.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TDOC.

Teladoc Health Inc [TDOC] Institutonal Ownership Details

The top three institutional holders of TDOC stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in TDOC stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in TDOC stock with ownership which is approximately 5.8325%.